Maaike Van Zon
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.
Journal: Nature communications
Published: June 05, 2025
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.
Journal: The British journal of surgery
Published: December 24, 2024
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
Journal: The New England journal of medicine
Published: December 08, 2022
MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial.
Journal: Immuno-oncology technology
Published: July 22, 2022
IL-1R1-Dependent Signals Improve Control of Cytosolic Virulent Mycobacteria In Vivo.
Journal: mSphere
Published: May 06, 2021
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.
Journal: Journal for immunotherapy of cancer
Published: June 23, 2020
Elaboration and validation of the method for the quantification of the emetic toxin of Bacillus cereus as described in EN-ISO 18465 - Microbiology of the food chain - Quantitative determination of emetic toxin (cereulide) using LC-MS/MS.
Journal: International journal of food microbiology
Published: August 29, 2017
ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria.
Journal: Cellular microbiology
Published: April 25, 2012
Mycobacterial secretion systems ESX-1 and ESX-5 play distinct roles in host cell death and inflammasome activation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 30, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026